エクソソームの市場規模、シェア、成長分析、製品別、ワークフロー別、用途別、最終用途別、地域別- 産業予測、2024～2031年

エクソソームの世界市場規模は、2022年に2億5,080万米ドルと評価され、2023年の3億2,579万米ドルから2031年には26億4,125万米ドルに成長し、予測期間中（2024～2031年）に29.9%のCAGRで成長する見通しです。

一般にエクソソームとして知られる細胞外小胞（EV）は、血清、尿、母乳など様々な体液に見られるユビキタス細胞伝達物質です。タンパク質や遺伝物質を輸送するその能力は、特にがんの増加に直面して、診断や治療において重要な役割を担っています。エクソソーム市場の主な促進要因としては、エクソソーム分離技術の進歩、研究資金の増加、2023年には1,000万人近くが死亡すると予測されるがんなどの疾病の発生率の増加などが挙げられます。パンデミックはまた、エクソソームベースのCOVID-19ワクチンの開発に代表されるイノベーションの触媒となっています。これらの小胞は、ドラッグデリバリーの効率や低毒性など、重要な治療上の利点を約束するものであり、それによって今後数年間、疾病検出や革新的治療のための急成長する市場を形成しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ

エクソソームの市場規模：製品・サービス別& CAGR（2024-2031）

• 市場概要
• キットと試薬
  • 分離キット
  • 浄化キット
  • 検出キット
• 機器
  • 超遠心分離機
  • フローサイトメーター
  • その他
• サービス
  • エクソソーム分離サービス
  • エクソソーム特性評価サービス
  • エクソソームプロファイリングサービス

エクソソームの市場規模：ワークフロー別& CAGR（2024-2031）

• 市場概要
• 分離方法
  • 超遠心分離
  • ビーズ上免疫捕捉法
  • 沈殿法
  • 濾過法
  • その他
• ダウンストリーム分析
  • フローサイトメトリー
  • 質量分析
  • 次世代シーケンシング（NGS）
  • ウエスタンブロッティング
  • その他

エクソソームの市場規模：用途別& CAGR（2024-2031）

• 市場概要
• がん
  • 肺がん
  • 乳がん
  • 前立腺がん
  • 大腸がん
  • その他
• 心血管疾患（CVD）
• 神経変性疾患
• 感染症
• その他

エクソソームの市場規模：最終用途別& CAGR（2024-2031）

• 市場概要
• 学術・調査機関
• 製薬・バイオテクノロジー企業
• 病院および臨床検査研究所

エクソソームの市場規模：地域別& CAGR（2024-2031）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2021-2023）

主要企業プロファイル

• QIAGEN（Germany）
• Takara Bio Company（Japan）
• Illumina, Inc.（USA）
• Thermo Fisher Scientific, Inc.（USA）
• Codiak Biosciences（USA）
• Exosome Diagnostics（USA）
• Evox Therapeutics（UK）
• ExCoBio Inc.（South Korea）
• Bio-Rad Laboratories Ltd.（USA）
• NanoSomix, Inc.（USA）
• System Biosciences（SBI）（USA）
• Lonza Group（Switzerland）
• Miltenyi Biotec（Germany）
• Norgen Biotek Corp.（Canada）
• AMS Biotechnology（AMSBIO）（UK）
• Creative Biolabs（USA）
• Capricor Therapeutics（USA）
• Aegle Therapeutics（USA）
• Anjarium Biosciences（Switzerland）

結論と推奨事項

Global Exosomes Market size was valued at USD 250.8 million in 2022 and is poised to grow from USD 325.79 million in 2023 to USD 2641.25 million by 2031, growing at a CAGR of 29.9% during the forecast period (2024-2031).

Extracellular vesicles (EVs), commonly known as exosomes, are ubiquitous cell communication agents found across various bodily fluids such as serum, urine, and breast milk. Their ability to transport proteins and genetic material positions them as crucial players in diagnostics and therapeutics, particularly in the face of rising cancer incidents. Key drivers for the EV market include advancements in exosome separation technologies, increased research funding, and the growing incidence of diseases like cancer-projected to account for nearly 10 million deaths in 2023. The pandemic has also catalyzed innovations, exemplified by the development of exosome-based COVID-19 vaccines. These vesicles promise significant therapeutic benefits, including drug delivery efficiency and low toxicity, thereby shaping a burgeoning market for disease detection and innovative treatments in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Exosomes market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Exosomes Market Segmental Analysis

Global Exosomes Market is segmented by product, workflow, application, end-use and region. Based on product, the market is segmented into kits & reagents, instruments and services. Based on workflow, the market is segmented into isolation methods and downstream analysis. Based on application, the market is segmented into cancer, cardiovascular diseases (CVD), neurodegenerative diseases, infectious diseases and others. Based on end-use, the market is segmented into academic & research institutes, pharmaceutical & biotechnology companies and hospitals & clinical testing laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Exosomes Market

The growth of the global exosomes market is largely driven by the rising investments in pharmaceutical research and development (R&D) along with life sciences initiatives. Pharmaceutical, biopharmaceutical, and medical device companies allocate substantial resources towards the advancement of innovative drugs and technologies. This investment in R&D is critical for the pharmaceutical industry, which prioritizes the delivery of high-quality, cutting-edge products. Recent trends indicate that major pharmaceutical firms are improving their R&D efficiency through substantial long-term funding and collaborative research ventures, ultimately fueling advancements in exosome technologies and applications across various therapeutic areas.

Restraints in the Global Exosomes Market

The global exosomes market faces significant constraints primarily due to the absence of established standard protocols for exosome development and production. As exosome research remains in its nascent stages, scientists often resort to employing novel techniques and methodologies with little hesitation. This lack of standardization not only presents challenges during the creation of exosomes but also complicates their research, development, and manufacturing processes. While exosomes derived from mesenchymal stem cells (MSCs) are garnering interest for their role as intercellular messengers, there is an urgent need for industry leaders to innovate effective harvesting techniques and develop comprehensive standards for exosome characterization and purification to advance their application in areas like vaccine development, cancer diagnostics, and gene therapy.

Market Trends of the Global Exosomes Market

The Global Exosomes market is experiencing a significant upward trend driven by the increasing recognition of exosomes as a versatile treatment platform for various conditions, notably including COVID-19. Their unique ability to deliver therapeutic cargo while minimizing immune rejection positions exosomes as a promising cell-free therapeutic option for numerous diseases and tissue regeneration applications. The growing interest in exosomal therapy, particularly for respiratory viral infections like SARS-CoV-2, underscores the potential of stem cell-derived exosomes to leverage anti-inflammatory and regenerative properties. This trend indicates a robust future for exosome-based treatments as they gain acceptance in the medical community.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Exosomes Market Size by Product & Service & CAGR (2024-2031)

• Market Overview
• Kits & Reagents
  • Isolation Kits
  • Purification Kits
  • Detection Kits
• Instruments
  • Ultracentrifuges
  • Flow Cytometers
  • Others
• Services
  • Exosome Isolation Services
  • Exosome Characterization Services
  • Exosome Profiling Services

Global Exosomes Market Size by Workflow & CAGR (2024-2031)

• Market Overview
• Isolation Methods
  • Ultracentrifugation
  • Immunocapture On Beads
  • Precipitation
  • Filtration
  • Others
• Downstream Analysis
  • Flow Cytometry
  • Mass Spectrometry
  • Next-Generation Sequencing (NGS)
  • Western Blotting
  • Others

Global Exosomes Market Size by Application & CAGR (2024-2031)

• Market Overview
• Cancer
  • Lung Cancer
  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Others
• Cardiovascular Diseases (CVD)
• Neurodegenerative Diseases
• Infectious Diseases
• Others

Global Exosomes Market Size by End-Use & CAGR (2024-2031)

• Market Overview
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Clinical Testing Laboratories

Global Exosomes Market Size & CAGR (2024-2031)

• North America (Product & Service, Workflow, Application, End-Use)
  • USA
  • Canada
• Europe (Product & Service, Workflow, Application, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Workflow, Application, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Workflow, Application, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Workflow, Application, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• QIAGEN (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Company (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Codiak Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exosome Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evox Therapeutics (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ExCoBio Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories Ltd. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NanoSomix, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• System Biosciences (SBI) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norgen Biotek Corp. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AMS Biotechnology (AMSBIO) (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Biolabs (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Capricor Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aegle Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anjarium Biosciences (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations